Overview

Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

Status:
COMPLETED
Trial end date:
2024-10-17
Target enrollment:
Participant gender:
Summary
No randomized controlled trial evaluated the safety and efficacy of double blockade on G-CSF induced bone pain. Therefore, this study aims to evaluate the efficacy and safety of double blockade on the incidence and severity of G-CSF induced bone pain.
Phase:
PHASE1
Details
Lead Sponsor:
Noha Mansour
Treatments:
Famotidine
Loratadine